Gabriel Brooks - Feb 13, 2024 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Chief Medical Officer
Signature
/s/ David Tyronne Howton as attorney-in-fact for Gabriel Brooks
Stock symbol
SLDB
Transactions as of
Feb 13, 2024
Transactions value $
$0
Form type
4
Date filed
2/16/2024, 11:56 AM
Previous filing
Oct 20, 2023
Next filing
Oct 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Employee Stock Option (Right to Buy) Award $0 +87.5K $0.00 87.5K Feb 13, 2024 Common Stock 87.5K $7.85 Direct F1
transaction SLDB Restricted Stock Units Award $0 +43.8K $0.00 43.8K Feb 13, 2024 Common Stock 43.8K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").
F3 The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.